Clinical trials in Odense – page 5

487 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Odense at a glance

487

clinical trials

Research sites4

Quick filters

487 trials in Odense

Open in trial search

B-cell type acute leukaemia

Recruiting

Study of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Study of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Denmark

Participants:0–17 years · 18–64 years
Substances:Blinatumomab
Sponsor:Universita Degli Studi Di Milano Bicocca

Contact Research Centre

Dilated cardiomyopathy

Recruiting

A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

Investigational

A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Danicamtiv
Sponsor:Kardigan Inc.

Contact Research Centre

Ovarian cancer

Recruiting

A Study of Carboplatin Given Directly into the Abdomen After Surgery in Elderly and Frail Patients with Ovarian Cancer

Registered drugNo placebo

A Study of Carboplatin Given Directly into the Abdomen After Surgery in Elderly and Frail Patients with Ovarian Cancer

Registered drugNo placebo

Denmark

Participants:65+ years
Substances:Carboplatin
Sponsor:Odense University Hospital

Contact Research Centre

Ovarian cancer

Recruiting

A Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer

Registered drugNo placebo

A Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Cervix carcinoma

Recruiting

A Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned

Registered drugNo placebo

A Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

A Study of Tulmimetostat and Luxdegalutamide Compared to Standard Treatment in Men with Advanced Prostate Cancer That No Longer Responds to Hormone Therapy

Registered drugNo placebo

A Study of Tulmimetostat and Luxdegalutamide Compared to Standard Treatment in Men with Advanced Prostate Cancer That No Longer Responds to Hormone Therapy

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Abiraterone
Sponsor:Novartis Pharma AG

Contact Research Centre

HIV infection

Recruiting

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Venetoclax
Sponsor:Region Midtjylland

Contact Research Centre

Pancreatic carcinoma metastatic+1

Recruiting

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Registered drug

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Gemcitabine
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Non-small cell lung cancer

Recruiting

A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:Pfizer Inc.

Contact Research Centre

Endometrial cancer metastatic

Recruiting

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:AZD8205
Sponsor:AstraZeneca AB

Contact Research Centre

Neoplasm malignant

Recruiting

A Study of MK-1084 Alone and Combined with Cetuximab for People with Advanced Solid Tumors that Have a KRAS G12C Gene Change

Registered drugNo placebo

A Study of MK-1084 Alone and Combined with Cetuximab for People with Advanced Solid Tumors that Have a KRAS G12C Gene Change

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Cetuximab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Bronchopulmonary dysplasia+1

Recruiting

A study on azithromycin for preventing airway infections in children aged 0-72 months with structural lung damage or congenital lung and airway malformations

Registered drug

A study on azithromycin for preventing airway infections in children aged 0-72 months with structural lung damage or congenital lung and airway malformations

Registered drug

Denmark

Participants:0–17 years
Substances:Azithromycin
Sponsor:Rigshospitalet

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

Pulmonary Fibrosis Treatment
Nasal Polyps Management
Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

Cancer-Related Fatigue
Advanced Breast Cancer
Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

Gastrointestinal Disorders
Immune System Disorders
Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

Kidney Transplantation
Cardiac Conditions
Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Back to Denmark All countries